case_images: PMC9433646_01
case_images: Medical history of the patient.
case_images: fonc-12-902301-g001.jpg
case_images: PMC9433646_01_fonc-12-902301-g001.jpg
case_images: f1
case_images: A timeline of the historical and current information is shown in  Figure 1 .
case_images: ASL-MRI on 9 February 2021 before GV-971 treatment (A), 29 July 2021 (B), and 18 January 2022 (C). After treatment with GV-971 (B, C), regions of low perfusion in green were visibly decreased.
case_images: fonc-12-902301-g002.jpg
case_images: PMC9433646_01_fonc-12-902301-g002.jpg
case_images: f2
case_images: Table 1 . The results for 14 cytokines and CAR-T cell copy numbers in peripheral blood samples from August 2021 are shown in  eTables 1 ,  2 .  Figure 2  shows the comparison of cerebral perfusion findings with 3D arterial spin labeling (ASL) imaging before and after treatment with sodium oligomannate.